T-CELL LEUKEMIA
Clinical trials for T-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at Hard-to-Treat T-Cell cancers
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD4CAR for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. The m…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC
-
Breakthrough trial aims to stop rare leukemia before it starts
Prevention Recruiting nowThis study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who have early warning signs in their T-cells. About 134 participants will receive a limited course of the drug to lower their viral load. The goal is t…
Matched conditions: T-CELL LEUKEMIA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 16, 2026 12:49 UTC
-
Rare leukemia study seeks to unlock secrets of T-PLL
Knowledge-focused Recruiting nowThis study is gathering information from 50 people with a rare and aggressive blood cancer called T-cell prolymphocytic leukemia (T-PLL). Researchers will look at medical records, lab results, and genetic data to better understand the disease and how patients respond to current t…
Matched conditions: T-CELL LEUKEMIA
Sponsor: French Innovative Leukemia Organisation • Aim: Knowledge-focused
Last updated May 26, 2026 12:00 UTC